FDA
approval
· 2023-03-02
FDA Approved: PIRFENIDONE — Supplemental Application (Accord Healthcare Inc.)
Summary
The FDA approved Accord Healthcare Inc.'s supplemental application to market a generic pirfenidone product for idiopathic pulmonary fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PIRFENIDONE (PIRFENIDONE)